April 17, 2024, 4:42 a.m. | Ruifeng Li, Dongzhan Zhou, Ancheng Shen, Ao Zhang, Mao Su, Mingqian Li, Hongyang Chen, Gang Chen, Yin Zhang, Shufei Zhang, Yuqiang Li, Wanli Ouyang

cs.LG updates on arXiv.org arxiv.org

arXiv:2404.10354v1 Announce Type: cross
Abstract: Artificial intelligence (AI) technology has demonstrated remarkable potential in drug dis-covery, where pharmacokinetics plays a crucial role in determining the dosage, safety, and efficacy of new drugs. A major challenge for AI-driven drug discovery (AIDD) is the scarcity of high-quality data, which often requires extensive wet-lab work. A typical example of this is pharmacokinetic experiments. In this work, we develop a physical formula enhanced mul-ti-task learning (PEMAL) method that predicts four key parameters of pharmacokinetics …

abstract artificial artificial intelligence arxiv challenge cs.ce cs.lg data discovery drug discovery drugs intelligence lab major multi-task learning prediction q-bio.qm quality quality data role safety technology type work

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Data Scientist

@ Publicis Groupe | New York City, United States

Bigdata Cloud Developer - Spark - Assistant Manager

@ State Street | Hyderabad, India